These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30914031)

  • 21. Natriuretic peptides in cardiometabolic regulation and disease.
    Zois NE; Bartels ED; Hunter I; Kousholt BS; Olsen LH; Goetze JP
    Nat Rev Cardiol; 2014 Jul; 11(7):403-12. PubMed ID: 24820868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential future therapies: natriuretic peptides.
    Lisy O; Burnett JC
    Coron Artery Dis; 1999 Sep; 10(6):389-94. PubMed ID: 10474789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natriuretic Peptides and Cardiometabolic Health.
    Gupta DK; Wang TJ
    Circ J; 2015; 79(8):1647-55. PubMed ID: 26103984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natriuretic peptides in heart failure.
    Richards AM
    Basic Res Cardiol; 2004 Mar; 99(2):94-100. PubMed ID: 14963668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart.
    Delgado R; Wadia Y; Kar B; Ethridge W; Zewail A; Pool T; Myers TJ; Scroggins N; Frazier OH
    J Heart Lung Transplant; 2005 Aug; 24(8):1166-70. PubMed ID: 16102467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between Left Ventricular Cavity Size and Cardiac Function and Overload Determined by Natriuretic Peptide Levels and a Covariance Structure Analysis.
    Yoshida J; Kawai M; Minai K; Ogawa K; Ogawa T; Yoshimura M
    Sci Rep; 2017 May; 7(1):2037. PubMed ID: 28515459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    Myhre PL; Vaduganathan M; Claggett B; Packer M; Desai AS; Rouleau JL; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2019 Mar; 73(11):1264-1272. PubMed ID: 30846338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1.
    Han B; Hasin Y
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):41-52. PubMed ID: 12843686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
    Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
    J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin Receptor-Neprilysin Inhibitors and the Natriuretic Peptide Axis.
    Vasquez N; Carter S; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):67-76. PubMed ID: 32394149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sacubitril/valsartan: beyond natriuretic peptides.
    Singh JSS; Burrell LM; Cherif M; Squire IB; Clark AL; Lang CC
    Heart; 2017 Oct; 103(20):1569-1577. PubMed ID: 28689178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics.
    Rubattu S; Volpe M
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac natriuretic peptides: from basic discovery to clinical practice.
    Hayek S; Nemer M
    Cardiovasc Ther; 2011 Dec; 29(6):362-76. PubMed ID: 20433683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies.
    Takei Y; Inoue K; Trajanovska S; Donald JA
    Gen Comp Endocrinol; 2011 May; 171(3):258-66. PubMed ID: 21362425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natriuretic peptides--relevance in cardiovascular disease.
    Cheung BM; Kumana CR
    JAMA; 1998 Dec; 280(23):1983-4. PubMed ID: 9863839
    [No Abstract]   [Full Text] [Related]  

  • 37. Natriuretic peptides as therapeutic targets.
    Mukaddam-Daher S
    Expert Opin Ther Targets; 2006 Apr; 10(2):239-52. PubMed ID: 16548773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of the trout cardiac natriuretic peptide system to manipulation of salt and water balance.
    Johnson KR; Olson KR
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1170-9. PubMed ID: 19176886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacubitril/Valsartan (LCZ696) in Heart Failure.
    Khder Y; Shi V; McMurray JJV; Lefkowitz MP
    Handb Exp Pharmacol; 2017; 243():133-165. PubMed ID: 28004291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical implications of current natriuretic peptide research.
    Sagnella GA
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):304-15. PubMed ID: 11967816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.